Ventricular fibrillation: Basic concepts

Pediatric Clinics of North America

Volumn 51, Issue 5, 2004, Pages 1211-1221

  Fish, Frank A ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMIODARONE; ANTIARRHYTHMIC AGENT; DOFETILIDE; FLECAINIDE; SODIUM CHANNEL BLOCKING AGENT; SOTALOL; VASOPRESSIN;

CARDIOVASCULAR RISK; DEFIBRILLATION; DEFIBRILLATOR; HEART ARREST; HEART ARRHYTHMIA; HEART DISEASE; HEART INFARCTION; HEART MUSCLE; HEART VENTRICLE FIBRILLATION; HUMAN; HYPOKALEMIA; NONHUMAN; PATHOGENESIS; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY; SUDDEN DEATH;

EID: 4344639268     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2004.04.010     Document Type: Review

References (34)

1. Gillum R.F. Sudden coronary death in the United States. Circulation. 79:1989;756-765
2. Moe G.K. On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn. CXL:1962;183-188
3. Gray R.A., Jalife J., Panfilov A.V., et al. Mechanisms of cardiac fibrillation. Science. 270:1995;1222-1223
4. Voroshilovsky O., Qu Z., Lee M.-H., et al. Mechanisms of ventricular fibrillation induction by 60 Hz alternating current in isolated swine right ventricle. Circulation. 102:2000;1569-1574
5. Persov A.M., Davidenko J.M., Salomonsz J.R., et al. Spiral waves of excitation underlie reentrant activity in isolated cardiac muscle. Circ Res. 72:1993;631-650
6. Weiss J.N., Chent P.-S., Qu Z., et al. Ventricular fibrillation: how do we stop the waves from breaking? Circ Res. 87:2002;1103-1107
7. Valderrabano M., Lee M.-H., Ohara T., et al. Dynamics of intramural and transmural reentry during ventricular fibrillation in isolated swine ventricles. Circ Res. 88:2001;839-848
8. Jalife J. Ventricular fibrillation: mechanisms of initiation and maintenance. Annu Rev Physiol. 62:2000;25-50
9. Rogers J.M., Huang J., Melnick S.B., et al. Sustained reentry in the left ventricle of fibrillating pig hearts. Circ Res. 92:2003;539-545
10. Weiss J.N., Garfunkel A., Karagueuzian H.A., et al. Chaos and the transition to ventricular fibrillation: a new approach to antiarrhythmic drug evaluation. Circulation. 99:1999;2819-2826
11. Samie F.H., Mandapati R., Gray R.A., et al. A mechanism of transition from ventricular fibrillation to tachycardia: effect of calcium channel blockade on the dynamics of rotating waves. Circ Res. 86:2000;684-691
12. Qin H., Walcott G.P., Killingswort C.R., et al. Impact of myocardial ischemia and reperfusion on ventricular defibrillation patterns, energy requirements, and detection of recovery. 2002;105:2537-2542
13. Spach M.S., Dolber P.C. Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle: evidence for electrical uncoupling of side-to-side fiber connections with increasing age. Circ Res. 58:1986;356-371
14. Jones J.L., Tovar O.H. Electrophysiology of ventricular fibrillation and defibrillation. Crit Care Med. 28:2000;N219-N221
15. Dalzell G.W.N. Determinants of successful defibrillation. Br Med J. 1998;405-407
16. Greene H.L., DiMarco J.P., Kudenchuk P.J., et al. Comparison of monophasic and biphasic defibrillating pulse waveforms for transthoracic cardioversion. Biphasic Waveform Defibrillation Investigators. Am J Cardiol. 75:1995;1135-1139
17. Tang W.C., Weil M.H., Jorgenson D., et al. Fixed-energy biphasic waveform defibrillation in a pediatric model of cardiac arrest and resuscitation. Crit Care Med. 30:2002;2736-2741
18. Oliver M.F. Metabolic causes and prevention of ventricular fibrillation during acute coronary syndromes. Am J Med. 112:2002;305-311
19. Ramaswamy K., Hamdan M.H. Ischemia, metabolic disturbances, and arrhythmogenesis: mechanisms and management. Crit Care Med. 28:2000;N151-N157
20. Clusin W.T. Calcium and cardiac arrhythmias: DADs, EADs and alternans. Crit Rev Clin Lab Sci. 40:2003;337-375
21. Priori S.G., Napolitano C., Vicentini A. Inherited arrhythmias syndromes: applying the molecular biology and genetic to the clinical management. J Interv Cardiac Electrophysiol. 9:2003;93-101
22. Roden D.M. Antiarrhythmic drugs: from mechanisms to clinical practice. Heart. 84:2000;339-346
23. Fogel R.I., Prystowsky E.N. Management of malignant ventricular arrhythmias and cardiac arrest. Crit Care Med. 28:2000;N165-N169
24. Echt D.S., Black J.N., Barbey J.T., et al. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel blockade and action potential prolongation. Circulation. 79:1989;1106-1117
25. Dorian P., Newman D. Effect of sotalol on ventricular fibrillation and defibrillation in humans. Am J Cardiol. 72:1993;72A-79A
26. Pelosi F. Jr., Oral H., Kim M.H., et al. Effect of chronic amiodarone on defibrillation energy requirements in humans. J Cardiovasc Electrophysiol. 11:2000;741-743
27. Schwartz P.J., Zipes D.P. Autonomic modulation of cardiac arrhythmias. Zipes D.P., Jalife J. Cardiac electrophysiology: from cell to bedside. 3rd edition:2000;WB Saunders, Philadelphia
28. Ditchey R.V., Rubio-Perez, Slinker B.K. Epinephrine increases the severity of post-resuscitation myocardial dysfunction. Circulation. 96:1997;683-688
29. Kern K.B., Ewy G.A., Voorhees W.D., et al. Myocardial perfusion pressure: a predictor of 24-h survival during prolonged cardiac arrest in dogs. Resuscitation. 16:1988;241-250
30. Krismer A.C., Wenzel V., Mayr V.D., et al. Arginine vasopressin during cardiopulmonary resuscitation and vasodilatory shock: current experience and future perspectives. Curr Opin Crit Care. 7:2001;157-169
31. Gazmuri R.J., Ayyoub I., Kolarova J.D., et al. Myocardial protection during ventricular fibrillation by inhibition of the sodium-hydrogen exchanger isoform-1. Crit Care Med. 2002;S166-S171
32. Voelckel W.G., Lurie K.G., McKnite S., et al. Effects of epinephrine and vasopressin in a piglet model of prolonged ventricular fibrillation and cardiopulmonary resuscitation. Crit Care Med. 30:2002;957-962
33. Anderson M.E., Al-Khatib S.M., Roden D.M., et al. Duke Clinical Research Insitute/American Heart Journal Expert Meeting on Repolarization Changes. Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management. Am Heart J. 144:2002;769-781
34. Haissaguerre M., Shoda M., Jais P., et al. Mapping and ablation of ventricular fibrillation. Circulation. 106:2002;962-967